NEUROIMAGE, published by Academic Press Inc Elsevier Science, is a leading international journal dedicated to advancing the fields of cognitive neuroscience and neurology. With an impressive impact factor that places it in the Q1 category for both disciplines, NEUROIMAGE stands at the forefront of disseminating high-quality research that employs advanced imaging methods to elucidate the workings of the human brain. As a pivotal platform since its inception in 1992, this journal has continued to thrive, embracing Open Access publishing since 2020 to ensure wider dissemination and accessibility of cutting-edge findings. With a Scopus rank of 7th in cognitive neuroscience and 13th in neurology, and situated in the 94th and 93rd percentiles respectively, NEUROIMAGE serves as an invaluable resource for researchers, professionals, and students alike seeking to explore the intricate relationships between brain structure and function. For more information, please visit their office at 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495.

Frontiers in Human Neuroscience is a premier open access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the complexities of human neuroscience. With an ISSN of 1662-5161, the journal has established its prominence in various fields, achieving a Q2 ranking in categories such as Behavioral Neuroscience, Neuropsychology and Physiological Psychology, and Psychiatry and Mental Health as of 2023. Since its inception in 2008, Frontiers in Human Neuroscience has consistently contributed to the scholarly dialogue by offering a platform for innovative research that bridges the gap between neuroscience and behavioral science. The journal's rigorous peer-review process and commitment to open access ensures that findings are readily available, promoting collaboration and progress within the academic community. With an impact on neuroscience disciplines, it stands at the forefront of the field, inviting researchers, professionals, and students alike to engage with cutting-edge studies and developments. The journal's address is located in Lausanne, Switzerland, where it continues to flourish as a hub for neurobiological exploration.

HUMAN BRAIN MAPPING, published by Wiley, is a premier journal in the field of neuroscience, devoted to comprehensively advancing understanding of brain structure and function through innovative mapping techniques. With an impressive impact factor and ranked in the Q1 category across multiple relevant disciplines—including Anatomy, Neurology, and Radiology—this journal is recognized as a vital resource for researchers and professionals passionate about the complexities of the human brain. Founded in 1993 and continuously publishing groundbreaking research, HUMAN BRAIN MAPPING is essential for those looking to stay at the forefront of developments in anatomical and neurological research. Though it does not currently offer Open Access options, the journal remains committed to disseminating high-quality research that influences clinical practices and academic inquiry. Its esteemed position within Scopus highlights its significance; charting at the top percentiles across various medical and health fields serves as a testament to the critical contributions made by the authors and researchers involved. As it converges toward 2024, HUMAN BRAIN MAPPING continues to be the go-to platform for publishing pivotal insights into the intricacies of brain mapping methodologies and applications.

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

NeuroImage-Clinical is a premier open access journal published by Elsevier Science Ltd, dedicated to advancing the field of clinical neuroimaging and its applications in a variety of neurological disorders. With an ISSN of 2213-1582, this journal has established itself as a leading source of innovative research since its inception in 2012, now continuing through 2024. Recognized for its high impact, it occupies the top quartile (Q1) in prestigious categories such as Cognitive Neuroscience, Neurology, and Radiology, affirming its relevance in clinical and research settings. Its Scopus rankings further exemplify its significant contribution to the disciplines of Radiology and Neurology, consistently placing it among the top tiers of journals in these fields. This journal not only provides critical insights for researchers and professionals but also serves as a valuable resource for students, fostering an understanding of the complexities in neuroimaging techniques and their implications for patient care. With open access options ensuring broad dissemination of knowledge, NeuroImage-Clinical plays a pivotal role in enhancing collaboration and innovation within the global neuroscience community.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, published by PERGAMON-ELSEVIER SCIENCE LTD in the United Kingdom, serves as a leading interdisciplinary platform for the dissemination of pioneering research and reviews in the realms of Neuroscience, Behavioral Neuroscience, Cognitive Neuroscience, and Neuropsychology. With an impressive impact factor reflected in its Q1 ranking across multiple categories for 2023, the journal is recognized for its rigorous peer-reviewed content that influences the advancement of scientific knowledge in behavioral and cognitive research. An essential resource for researchers, professionals, and students alike, the journal emphasizes the exploration of complex neural mechanisms that underlie behavior and cognitive processes. Despite being a subscription-based publication, the journal's extensive archive from 1978 to 2024 fosters a wealth of knowledge designed to inspire and facilitate future advancements within the field.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

PSYCHOPHYSIOLOGY, published by WILEY, stands as a leading journal in the intersection of psychology and physiology, contributing significantly to our understanding of the brain and body connection since its inception in 1964. With an impressive scope covering areas such as biological psychiatry, cognitive neuroscience, and neuropsychology among others, the journal has earned multiple Q1 rankings in these critical domains as of 2023, reflecting its high impact in the field. The journal ranks particularly well in categories such as Experimental and Cognitive Psychology and neurology, indicating its status as a pivotal resource for professionals and researchers committed to advancing knowledge in psychophysiological studies. Furthermore, with an e-ISSN of 1469-8986, PSYCHOPHYSIOLOGY is accessible to a global audience, although it is not part of the Open Access movement, ensuring that its rigorous research remains a trusted source for academic excellence. By engaging with this journal, readers can expect to discover pioneering research and significant findings that push the boundaries of current understanding, making it an essential publication for those invested in the advancements of psychological and physiological sciences.

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.